Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241485 | 0.87 | TLR7 (0.33) | TLR7TLR8ALOX5APPSIP1CYP3A4 | |
| SCHEMBL241486 | 0.87 | TLR7 (0.33) | TLR7TLR8ALOX5APPSIP1CYP3A4 | |
| SCHEMBL20021129 | 0.86 | MCHR1 (0.32) | PSIP1CYP3A4 | |
| SCHEMBL15182607 | 0.85 | CYP3A4 (0.37) | TLR7TLR8ALOX5APPSIP1CYP3A4 | |
| SCHEMBL245419 | 0.85 | PSIP1 (0.45) | TLR7TLR8PSIP1CYP3A4KMT2A | |
| SCHEMBL20021172 | 0.82 | MEN1 (0.36) | PSIP1KMT2A | |
| SCHEMBL20020741 | 0.78 | GRM2 (0.35) | PSIP1CYP3A4DHODH | |
| SCHEMBL15182729 | 0.78 | PSIP1 (0.37) | PSIP1CYP3A4KMT2AATMDHODH | |
| SCHEMBL244789 | 0.77 | CRHR1 (0.33) | ALOX5APPSIP1CYP3A4 | |
| SCHEMBL244790 | 0.77 | CRHR1 (0.33) | ALOX5APPSIP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588455-B1 | 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2018-04-04 | — | — | EP | disclosed |